Metabolic Endotoxemia and Gut Microbiota Interactions

Metabolic endotoxemia describes the translocation of low levels of bacterial endotoxin, principally lipopolysaccharide (LPS), from the intestinal lumen into the bloodstream. This process is intricately linked to the intestinal barrier and its resident microbial community. Under normal conditions, a balanced gut microbiota contributes to barrier integrity and immune homeostasis. Disruption of this balance, termed dysbiosis, alongside dietary and environmental factors, can increase intestinal permeability and promote LPS absorption. Circulating LPS engages innate immune receptors, notably Toll-like receptor 4, triggering low-grade systemic inflammation that underpins metabolic disorders such as obesity, insulin resistance and non-alcoholic fatty liver disease. Recent advances have illuminated the cellular pathways by which microbial products cross the epithelium, the signalling cascades that ensue, and the reciprocal influence of host immunity on microbiota composition. Elucidating these interactions highlights potential avenues for therapeutic intervention, from dietary modulation to targeted cytokine therapies, with global implications for the management of chronic inflammatory diseases.

Research from Nature Portfolio

Prolonged consumption of a high-fat diet has been shown to induce endoplasmic reticulum and oxidative stress in colonic goblet cells, compromising mucus production and tight junction integrity. These changes facilitate endotoxin leakage into the circulation and amplify intestinal inflammation. Intervention with the cytokine interleukin-22 restored mucosal barrier function, reduced epithelial stress and reversed dysbiotic shifts in microbial communities, demonstrating a promising immunomodulatory strategy to counter metabolic endotoxemia and its sequelae.

Metabolic Endotoxemia and Gut Microbiota Interactions publication trend

The graph below shows the total number of articles in metabolic endotoxemia and gut microbiota interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Lipopolysaccharide (LPS): A major component of Gram-negative bacterial outer membranes that acts as an endotoxin when entering the bloodstream.

Metabolic endotoxemia: A condition characterised by persistently elevated plasma LPS levels that drive low-grade systemic inflammation.

Gut microbiota: The diverse community of microorganisms residing in the gastrointestinal tract, essential for nutrient metabolism and immune regulation.

Intestinal permeability: A measure of the barrier function of the gut epithelium that regulates passage of macromolecules and microbial products.

Dysbiosis: An imbalance in the composition and function of the gut microbiota associated with disease states.

References

1. Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Frontiers in Immunology (2021).
2. Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors. Nutrients (2019).
3. High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22. Scientific Reports (2016).
4. Multifunctional dietary approach reduces intestinal inflammation in relation with changes in gut microbiota composition in subjects at cardiometabolic risk: the SINFONI project. Gut Microbes (2024).
5. Sugar-sweetened beverage but not diluted cloudy apple juice consumption induces post-prandial endotoxemia in healthy adults. npj Science of Food (2024).
6. High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway. PLOS ONE (2012).